Navigation Links
Cancer requires support from immune system to develop, UT Southwestern researchers report
Date:10/30/2008

urgically because too many blood vessels were involved. Because Gleevec is already approved for other conditions, the girl's doctor treated her under "compassionate use" guidelines.

The girl's tumor shrank by 70 percent with no apparent side effects during the first three months of a six-month treatment under "compassionate use" regulations. The mass has remained dormant in the six months afterward, the researchers reported.

While this was only a single case, it was consistent with the one-year study of the tumor and its action in mice, Dr. Parada said, and the child's treatment was tailored to reflect the findings from the animal study.

A phase 2 clinical trial of this treatment in people with neurofibromatosis has been approved and is under way.

Dr. Parada cautioned, however, that further research is needed. A single human case, while encouraging, is not enough to prove the long-term effectiveness of the treatment, and Gleevec might be exerting other actions in addition to inhibiting mast cells.


'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer requires support from immune system to develop, UT Southwestern researchers report
Cancer requires support from immune system to develop, UT Southwestern researchers report
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... could be linked to scans performed in 2007 , , ... are exposing patients to far more radiation than previously thought ... cancers a year, two new studies claim. , Based on ... Archives of Internal Medicine , the study authors, joined ... calling on clinicians to limit radiation exposure to patients. , ...
(Date:12/14/2009)... , , MONDAY, Dec. 14 (HealthDay News) -- Here,s good ... a cup or two of java: Coffee and tea ... diabetes. , That,s the conclusion of an Australian ... the lower your risk of diabetes. Every cup of ... the risk of diabetes, the researchers said. , ...
(Date:12/14/2009)... are linked to an increased risk of certain cancers. ... synthetic insulin preparation marketed under the trade name Lantus), ... cancers than other insulins or oral glucose lowering medications. ... important factors such as obesity that may have driven ... large randomized trial designed to examine another aspect of ...
(Date:12/14/2009)... COPD, researchers say , , MONDAY, Dec. 14 (HealthDay News) ... lung function, a finding that may help lead to ... of researchers compared lung function with genetic variants at ... genome in more than 20,000 people of European ancestry. ... variants associated with alterations in lung function. , The ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... Medicine Cabinet Day Set For Saturday October 13,Proper ... OTC Drug Abuse, CHICAGO, Oct. 8 ... treatment to adolescents, adults and their,families, said today ... an area wide "Clean Out Your Medicine Cabinet" ...
... men who have surgery for prostate cancer appear less likely ... who choose other treatment options, especially if they are younger ... a report in the Oct. 8 issue of Archives of ... treatments are still being debated because they have not yet ...
... Center researcher has been awarded a National Institutes of ... factors, in addition to traditional predictors, can be useful ... disease. , Kevin A. Fiscella, M.D., M.P.H., associate professor ... by the National Heart, Lung and Blood Institute, part ...
... Study finds it outperforming other forms of treatment , ... the best chance of long-term survival for prostate cancer ... University found that prostate cancer patients who had surgery ... 10 years than men who had other types of ...
... of Parkinson,s patients more likely to develop dementia, study ... Relatives of people with Parkinson,s disease face up to ... suggests a new study that says genetics could be ... of the central nervous system, such as impaired motor ...
... WASHINGTON, Oct. 8 Crowell & Moring LLP ... Rhoad to the firm,s,Health Care and False Claims ... represents both health care and government contract clients,in ... Claims Act,(FCA), antitrust claims, and criminal and civil ...
Other Medicine News:Health News:Rosecrance and Chicago's Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs 2Health News:Rosecrance and Chicago's Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs 3Health News:Swiss study suggests surgery may offer best chance of long-term prostate cancer survival 2Health News:Study to consider social risk in guiding prevention of heart disease 2Health News:Surgery Best Bet for Prostate Cancer Survival 2Health News:Parkinson's Linked to Risk of Alzheimer's 2Health News:Crowell & Moring's Expanding Health Care Litigation Practice Gains Experienced Litigator 2Health News:Crowell & Moring's Expanding Health Care Litigation Practice Gains Experienced Litigator 3
(Date:12/14/2009)... today announced that executives of the company will address ... Sachs CEO Unplugged Conference on Jan. 6 at ... New York. 28th Annual J.P. Morgan Healthcare ... the Westin St. Francis Hotel in San Francisco. ... Health,s diverse products and services, company performance and strategies ...
(Date:12/14/2009)... Dec. 14 Greenway Medical ... integrated EHR, Prime Suite (®) ... 2011 Ambulatory EHR, additionally certified for Child ... Reporting. Greenway,s Prime Suite 2011 achieved ... certification designations offered by the Certification Commission ...
(Date:12/14/2009)... -- Cardium Therapeutics (NYSE Amex: CXM ) ... GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," ... Industry Conference held December 10-13, 2009 in St. ... attended by top industry leaders and renowned researchers ... Dr. Barbara K. Sosnowski, Cardium,s Vice President of ...
Breaking Medicine Technology:Cardinal Health Executives to Speak at Two Investor Events in January 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Scientists discover gene module underlying atherosclerosis development 10995 1Scientists discover gene module underlying atherosclerosis development 10995 2How nutrition affects healthy aging 10992 1How nutrition affects healthy aging 10992 2Miami Dentist Dr H A Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 62601 1Miami Dentist Dr H A Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 62601 2
... than 70 abstracts highlight VELCADE efficacy in broad ... CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, ... leading therapy with unsurpassed single-agent,efficacy for patients with ... the upcoming International Myeloma,Workshop (IMW) in Kos, Greece, ...
... Describes Identification, Characterization and Broad,Neuroprotective Properties of ... , Neurodegenerative Disease Specialists Publish Details of ... Mitochondrial Proteins , MARSEILLE, June 19th, 2007 ... the discovery and development of drugs for,neurological ...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: